1.
AJR Am J Roentgenol
; 211(3): 712-713, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30016145
RESUMO
OBJECTIVE: The purpose of this article is to report on a study conducted to determine whether the lesions in patients with what is deemed to be low-risk ductal carcinoma in situ (DCIS) selected for two large clinical trials are in fact low-risk lesions. CONCLUSION: A retrospective review was conducted to determine whether the eligibility criteria of the two trials are predictive that DCIS is low risk. More than 20% of lesions are upgraded to invasive carcinoma in patients with low-risk DCIS as defined in two large clinical trials. More accurate methods are needed to determine whether patients with a diagnosis of low-grade DCIS can be treated less aggressively.
Assuntos
Neoplasias da Mama/diagnóstico por imagem , Neoplasias da Mama/patologia , Carcinoma Intraductal não Infiltrante/diagnóstico por imagem , Carcinoma Intraductal não Infiltrante/patologia , Seleção de Pacientes , Feminino , Humanos , Gradação de Tumores , Estudos Observacionais como Assunto , Estudos Retrospectivos
2.